{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:04:58Z","timestamp":1792098298149,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010012","name":"National Aerospace Science Foundation of China","doi-asserted-by":"publisher","award":["31271201"],"award-info":[{"award-number":["31271201"]}],"id":[{"id":"10.13039\/501100010012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2015JQ8299"],"award-info":[{"award-number":["2015JQ8299"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.physbeh.2016.03.016","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T22:31:21Z","timestamp":1458081081000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-\u03b2 peptide-induced impairment of spatial learning and memory in rats"],"prefix":"10.1016","volume":"159","author":[{"given":"Xiao-Tao","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ye-Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yuan-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Li","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-shun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-5125","authenticated-orcid":false,"given":"Yan-Fang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2016.03.016_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2009.06.035","article-title":"Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer's disease","volume":"205","author":"Abbas","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2007.03.001","article-title":"A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25\u201335)","volume":"180","author":"Alkam","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"Pt A","key":"10.1016\/j.physbeh.2016.03.016_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer's disease: past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00441-001-0472-0","article-title":"Bax and other pro-apoptotic Bcl-2 family \u201ckiller-proteins\u201d and their victim the mitochondrion","volume":"306","author":"Antonsson","year":"2001","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2010.01.004","article-title":"Age-related loss of phospholipid asymmetry in APP(NLh)\/APP(NLh)\u00d7PS-1(P264L)\/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease","volume":"38","author":"Bader Lange","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"825","key":"10.1016\/j.physbeh.2016.03.016_bb0030","first-page":"e1","article-title":"Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity","volume":"33","author":"Bao","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2014.02.022","article-title":"Lixisenatide rescues spatial memory and synaptic plasticity from amyloid beta protein-induced impairments in rats","volume":"277","author":"Cai","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2008.06.034","article-title":"MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G","volume":"272","author":"Chen","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0050","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nn.2709","article-title":"Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease","volume":"14","author":"D'Amelio","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0065","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2011-1795","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro","volume":"153","author":"Dalvi","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0070","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0962-8924(00)01803-1","article-title":"Mitochondria as the central control point of apoptosis","volume":"10","author":"Desagher","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"Esparza","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","article-title":"Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice","volume":"33","author":"Gengler","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0100","first-page":"178","article-title":"Targeting apoptosis pathways in cancer therapy","volume":"55","author":"Ghobrial","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00018-009-9070-1","article-title":"Common features between diabetes mellitus and Alzheimer's disease","volume":"66","author":"Gotz","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jnr.22565","article-title":"Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain","volume":"89","author":"Hamilton","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2012.10.129","article-title":"Soluble oligomers and fibrillar species of amyloid beta-peptide differentially affect cognitive functions and hippocampal inflammatory response","volume":"429","author":"He","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0135","doi-asserted-by":"crossref","first-page":"e67898","DOI":"10.1371\/journal.pone.0067898","article-title":"A Luminex assay detects amyloid beta oligomers in Alzheimer's disease cerebrospinal fluid","volume":"8","author":"Herskovits","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0140","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jalz.2013.12.009","article-title":"The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease","volume":"10","author":"Holscher","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-2952(01)00924-8","article-title":"Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1","volume":"63","author":"Idris","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/CS20080090","article-title":"Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes","volume":"116","author":"Jin","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0160","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-2009-0973","article-title":"Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes","volume":"16","author":"Jones","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0165","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI66827","article-title":"FcgammaRIIb mediates amyloid-beta neurotoxicity and memory impairment in Alzheimer's disease","volume":"123","author":"Kam","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0175","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1242077","article-title":"Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model","volume":"341","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0180","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2009.04.005","article-title":"Protection against Abeta-mediated rapid disruption of synaptic plasticity and memory by memantine","volume":"32","author":"Klyubin","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0185","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1038\/cddis.2012.43","article-title":"Inhibition of Bax protects neuronal cells from oligomeric Abeta neurotoxicity","volume":"3","author":"Kudo","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0190","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.peptides.2008.06.019","article-title":"The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues","volume":"29","author":"Kunesova","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0195","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0200","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-beta oligomers in ageing and Alzheimer's disease","volume":"136","author":"Lesne","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0205","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: a review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0210","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3233\/JAD-2010-1314","article-title":"GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease","volume":"19","author":"Li","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0215","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3233\/JAD-2009-1022","article-title":"Adiposity, type 2 diabetes, and Alzheimer's disease","volume":"16","author":"Luchsinger","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0230","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s11064-012-0872-4","article-title":"Genistein inhibits Abeta(25\u201335)-induced neurotoxicity in PC12 cells via PKC signaling pathway","volume":"37","author":"Luo","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0240","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0165-6147(03)00160-3","article-title":"The glucagon-like peptides: a double-edged therapeutic sword?","volume":"24","author":"Perry","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0245","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.037481","article-title":"Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4","volume":"302","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"Perry","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0255","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"Perry","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.10611","article-title":"Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron","volume":"72","author":"Perry","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0265","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/156720506775697142","article-title":"A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis","volume":"3","author":"Sambamurti","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0275","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","article-title":"Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior","volume":"192","author":"Selkoe","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0280","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0285","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jnc.12469","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress","volume":"128","author":"Sharma","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.05.035","article-title":"Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease","volume":"1280","author":"Takeda","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0295","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neuroscience.2010.08.028","article-title":"Val8-glucagon-like peptide-1 protects against Abeta1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats","volume":"170","author":"Wang","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hipo.22202","article-title":"The neuroprotection of Rattin against amyloid beta peptide in spatial memory and synaptic plasticity of rats","volume":"24","author":"Wang","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0305","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nn.2476","article-title":"Amyloid beta from axons and dendrites reduces local spine number and plasticity","volume":"13","author":"Wei","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0310","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2016.03.016_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","article-title":"New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF","volume":"9","author":"Yang","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0320","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuint.2008.12.010","article-title":"Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins","volume":"54","author":"Yenkoyan","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0325","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/emboj.2013.207","article-title":"Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin","volume":"32","author":"Zempel","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000332816","article-title":"Linking amyloid-beta and tau: amyloid-beta induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton","volume":"10","author":"Zempel","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exger.2009.08.002","article-title":"Amyloid beta and APP as biomarkers for Alzheimer's disease","volume":"45","author":"Zetterberg","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.physbeh.2016.03.016_bb0340","doi-asserted-by":"crossref","first-page":"e27019","DOI":"10.1371\/journal.pone.0027019","article-title":"Anesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Abeta oligomerization","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938416301007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938416301007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:01:13Z","timestamp":1758477673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938416301007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":68,"alternative-id":["S0031938416301007"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2016.03.016","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-\u03b2 peptide-induced impairment of spatial learning and memory in rats","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2016.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}